Publications by authors named "Lysel Brignoli"
Corrigendum to "Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey" [World Allergy Organ J 16 (3) (2023) 100724].
World Allergy Organ J
November 2024
[This corrects the article DOI: 10.1016/j.waojou.
View Article and Find Full Text PDFBackground: Few large-scale international studies have broadly characterized the burden of atopic dermatitis (AD) across age groups among children and adolescents.
Objectives: To better characterize the AD burden in paediatric patients by disease severity.
Methods: This cross-sectional, web-based survey of paediatric patients (6 months to < 18 years old) was conducted in 18 countries representing North America, Latin America, Europe, Middle East/Eurasia and East Asia.
Article Synopsis
- - This study aims to clarify the prevalence and severity of atopic dermatitis (AD) in adults across various regions, including Asia, Eurasia, and Latin America, revealing significant gaps in current understanding.
- - An international web-based survey collected data from multiple countries, finding AD prevalence varies from 3.4% in Israel to 33.7% in Thailand, often higher in females, with mild and moderate cases being more common than severe cases.
- - Results indicate that AD is a significant health concern in adults, challenging the notion that it predominantly affects children, as many respondents experience chronicity and high morbidity related to the condition.
Objective: To evaluate the impact of atopic dermatitis on families of pediatric patients.
Study Design: This cross-sectional, web-based survey of children/adolescents (6 months to <18 years old) with atopic dermatitis and their parents and caregivers was conducted in 18 countries encompassing North America, Latin America, Europe, Middle East/Eurasia, and East Asia. Children and adolescents with atopic dermatitis and their parents and caregivers were identified by the International Study of Asthma and Allergies in Childhood criteria and ever being told by a physician that they had "eczema".
Background: Little is known on the current global prevalence of atopic dermatitis (AD) in the pediatric population.
Objective: To estimate the real-world global prevalence of AD in the pediatric population and by disease severity.
Methods: This international, cross-sectional, web-based survey of children and adolescents (6 months to <18 years old) was conducted in the following 18 countries: North America (Canada, United States), Latin America (Argentina, Brazil, Columbia, Mexico), Europe (France, Germany, Italy, Spain, United Kingdom), Middle East and Eurasia (Israel, Saudi Arabia, Turkey, United Arab Emirates, Russia), and East Asia (Japan, Taiwan).